ACADIA PHARMACEUTICALS INC (ACAD)

↓ Download CSV

CIK 0001070494 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, ACADIA PHARMACEUTICALS INC reported revenue of $1.07B, up 11.9% from the prior year. The company was profitable, with a net margin of 36.5%. It held $1.56B in total assets against $336.81M in total liabilities.

Key ratios (FY2025)

9.8%
Operating margin
36.5%
Net margin
31.9%
Return on equity
+11.9%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$1.07B$957.80M$726.44M$517.24M$484.14M$441.75M$339.08M$223.81M$124.90M$17.33M
Cost of Revenue$89.00M$81.84M$41.64M$10.17M$19.14M$10.21M$11.34M$12.38M$9.08M
Gross Profit$684.80M$507.07M$473.30M$431.54M$327.73M$211.43M$115.82M$14.25M
Operating Income$104.81M$230.79M-$73.38M-$223.60M-$170.44M-$286.59M-$246.54M-$247.44M-$292.41M-$272.81M
Net Income$391.00M$226.45M-$61.29M-$215.97M-$167.87M-$281.58M-$235.26M-$245.19M-$289.40M-$271.39M
EPS (Diluted)$2.30$1.36$-0.37$-1.34$-1.05$-1.79
Total Assets$1.56B$1.19B$748.96M$587.81M$700.12M$782.62M$783.18M$540.20M$384.51M$561.15M
Total Liabilities$336.81M$454.96M$317.20M$187.40M$159.23M$155.61M$84.05M$61.12M$49.22M$42.74M
Shareholders' Equity$1.23B$732.79M$431.75M$400.41M$540.89M$627.01M$699.13M$479.08M$335.29M$518.41M
Cash & Equivalents$177.69M$319.59M$188.66M$114.85M$147.44M$326.03M$189.68M$134.76M$69.42M$163.62M
Operating Cash Flow$109.84M$157.72M$16.70M-$114.03M-$125.66M-$136.17M-$151.13M-$167.47M-$217.76M-$208.41M
Capital Expenditures$4.69M$523.0K$50.0K$0$1.12M$7.59M$1.13M$2.10M$812.0K$1.51M
Shares Outstanding170.31M166.71M164.65M162.06M161.01M159.64M155.28M143.85M124.41M121.37M